Dr. Dídac Mauricio, head of the Endocrinology, Diabetes and Nutrition Research Group at the Sant Pau Research Institute and director of the Endocrinology and Nutrition Department at Sant Pau Hospital, has been appointed the new scientific director of CIBERDEM (Center for Networked Biomedical Research on Diabetes and Associated Metabolic Diseases) by the Permanent Commission of CIBER, an entity dependent on the Carlos III Health Institute. In this way, he takes over from Dr. Eduard Montanya, who had held this position since 2015. Currently, Dr. Mauricio is also the director of one of the research groups at CIBERDEM.
He holds a degree in Medicine and Surgery from the University of Barcelona (1985) and a doctorate in Medicine from the Autonomous University of Barcelona (1993). He has been a specialist in Endocrinology and Nutrition since 1990. His clinical career has developed in five hospitals in Catalonia, in some of which he has served as department head: Hospital de Sabadell, Arnau de Vilanova University Hospital in Lleida, and, in an acting capacity, at Germans Trias i Pujol University Hospital in Badalona. At Sant Pau Hospital, he has worked in the Endocrinology and Nutrition Department as a resident (1986-1990), predoctoral researcher (1990-1991), unit director (2003-2006), and, since February 2018, as department head. Since 2019, the department head role has been shared between Sant Pau Hospital and Dos de Maig Hospital.
In the academic field, he has been an associate professor at the Faculty of Medicine of the University of Lleida (2008-2013) and, initially an associate professor from 2020, since September 2022 he has been a full professor at the Faculty of Medicine of the University of Vic-Central University of Catalonia.
In his research career, it is noteworthy that in 1994-1995 he was a postdoctoral researcher at the Steno Diabetes Center & Hagedorn Research Institute in Denmark. Dr. Mauricio has more than 340 indexed publications, has been the principal investigator of multiple research projects in national and international competitive calls, and is a member of the editorial board of various international journals. Since November 2020, he has been the president of the Diabetes Advisory Council in Catalonia, Department of Health, Government of Catalonia.
CIBERDEM is a Spanish public consortium whose main objectives are to lead the excellent research effort in diabetes and related metabolic diseases, and also to accelerate the translation of scientific results into clinical practice. CIBERDEM has an innovative structure comprising 29 reference groups located in different hospitals, universities, and research centers throughout Spain. Constituted in December 2007 on the initiative of the Carlos III Health Institute, it is made up of another 19 consortium institutions from 6 autonomous communities.
